|
Delayed
Toronto S.E.
23:10:06 16/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 9.250 CAD | -5.52% |
|
-13.63% | +16.79% |
| 10-05 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
| 10-05 | Satellos Bioscience Receives US Patent for Forazapadin | MT |
Chart: Technical Analysis
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| MSCL | Delayed | |
CBOE
| MSLE | Real-time | |
|
Nasdaq
| MSLE | Delayed | |
|
Deutsche Boerse AG
| 0IT | Delayed | |
|
Tradegate
| 0IT | Real-time | |
|
Börse Stuttgart
| 0IT | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 11.13 | 14.38 | 17.01 |
| Spread/Res. | -16.89% | -35.67% | -45.62% |
| Spread/Supp. | +17.24% | +17.24% | +15.34% |
| Support | 7.89 | 7.89 | 8.02 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MSCL Stock
- Charts Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
